
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Journal
- Events
- Suppliers
- Home
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Events
- Suppliers
Lallemand Bio-Ingredients president and general manager Lars Asferg unravels the potential in the company’s recent acquisition of Swiss biotechnology firm Evolva. Asferg discusses how Evolva’s precision fermentation tech could boost Lallemand’s health and flavor and fragrance businesses. He also outlines the business unit’s key focuses for 2024.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement













